What is Epidiolex?
While it’s easy to dismiss CBD(cannabidiol) as another fad remedy, seemingly hyped by stoners with an agenda, the cannabis compound is far from a weed dream. The Food and Drug Administration (FDA) has approved CBD as a viable prescription to treat rare forms of epilepsy, particularly that of Dravet syndrome in children.
A common misconception preventing CBD from gaining traction as a trustworthy treatment is that it is frequently associated with the “high” that comes with using recreational marijuana.
So why would the FDA approve a controversial drug as a remedy for epilepsy? Because CBD, although derived from marijuana, does not contain the ingredient THC, the main psychoactive component responsible for that euphoric “high.”
Clinical trials have concluded that CBD was effective in decreasing the frequency of seizures in children with Dravet syndrome, a severe form of epilepsy characterized by prolonged seizures and developmental delay.
CBD has also proven an effective treatment for common ailments such as inflammation, anxiety, seizures, and other conditions.
The recent FDA approval marks a historical step forward to demystifying any misconceptions of CBD, and allowing patients to uncover a potentially valuable treatment for a variety of conditions.